
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Rise Streak: second straight session with 30.85% cumulative gain
Updated: 15 Oct 2026 • 9:41 am
Posted by:

HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak is active in a second straight session. The stock last traded at Rs 156.95, up 9.11%, with market capitalisation at Rs 126.68 Cr. The price move is confirmed in Univest data; a company-specific reason has not been established.
For readers tracking HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak, the key point is not only the latest move but also the two-session pattern. A run of consecutive higher sessions can make HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak more relevant than a one-day change because it shows how the latest trading path has developed across back-to-back sessions. The company remains a small market capitalisation name at Rs 126.68 Cr, so the move is best read alongside valuation, business context and the healthcare sector backdrop rather than in isolation.
HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak: Consecutive Gain Analysis
HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak also matters because the streak has lifted the stock from Rs 119.95 at the start of the run to Rs 156.95 now, a cumulative gain of 30.85%. According to latest Univest data, the pattern is confirmed, but the figures do not establish a company-specific reason for the move. That is the central lens for this HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak update.
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) rose to Rs 156.95 from the previous close of Rs 143.85, a move of Rs 13.1 or 9.11%. The stock opened at Rs 148.5, reached a high of Rs 156.95, recorded a low of Rs 148.5.
HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak kept the stock higher again, with the latest traded price at Rs 156.95 versus the previous close of Rs 143.85. The move amounted to Rs 13.10, or 9.11%, and the stock traded from Rs 148.50 to Rs 156.95 during the day. The latest price sat at the top of the range, which keeps HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak in clear focus.
The day opened at Rs 148.50, matched the low at Rs 148.50 and later touched Rs 156.95, which was also the high. That sequence shows a narrow intraday band and places HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak within a compact trading range. Market capitalisation stood at Rs 126.68 Cr, so the move has taken place in a relatively modest size base. For readers following HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak, the practical takeaway is that the current session extended the prior day’s direction without needing any unsupported explanation. The next step is to see how the valuation backdrop looks after the streak.
What the Consecutive Gains Show
For HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak, the two sessions also differ in magnitude. The latest session added 9.11%, after the starting level of the run was Rs 119.95 on 2026-10-14. That makes the latest price action more than a standalone intraday event: it is part of a run that has already reset the stock’s level. According to latest Univest data, the pattern is confirmed, while the reason remains unestablished. HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak therefore deserves attention as a sequence, not a single-point move.
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 126.68 crore |
| P/E Ratio | 17.14x |
| P/B Ratio | 2.95x |
| EPS | Rs 8.39 |
| Book Value Per Share | Rs 48.69 |
| Dividend Yield | 0% |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 17.14x, P/B 2.95x. These ratios show where the company stands today and are not a call to buy or sell.
HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 126.68 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.14x, P/B at 2.95x should be read against the sector and peer benchmarks rather than as a standalone signal. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.14x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 46.92x |
| Benchmark P/E Range | 3.13x to 654.72x |
| Company P/B Ratio | 2.95x |
| Benchmark Median P/B | 2.84x |
| Benchmark Median ROE | 11.61% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 126.68 crore |
| Benchmark Median Market Cap | Rs 827.89 crore |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 17.14x, which is below the benchmark median of 31.35x, a difference of -45.33%. A P/E difference of this kind is a reference point rather than a recommendation.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,24,466.35 | 34.69 | 4.85 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,222.11 | 81.95 | 13.57 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,76,300.5 | 80.12 | 19.47 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,12,817.68 | 24.84 | 4.16 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,10,823.44 | 100.61 | 19.51 | 18.31 | 18.2 |
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 17.14x compared with the displayed peer median of 80.12x. This is a relative valuation comparison, not a buy or sell signal. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 126.68 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching HIMALAYA NUTRAVEDICS INDIA LIM
- HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak is in a second straight session, with the latest price at Rs 156.95.
- The cumulative gain across the streak is 30.85%, starting from Rs 119.95 on 2026-10-14.
- Market capitalisation is Rs 126.68 Cr, which keeps the move in a compact company-size context.
- P/E at 17.14 and P/B at 2.95 help frame the valuation after the rise.
- Healthcare and Pharmaceuticals & Drugs benchmarks show the stock below the industry median on P/E but slightly above the median on P/B.
About HIMALAYA NUTRAVEDICS INDIA LIM
HIMALAYA NUTRAVEDICS INDIA LIM operates in Healthcare within the Pharmaceuticals & Drugs industry. For a reader following HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak, the useful context is that the stock belongs to a sector where valuation, return ratios and market capitalisation are often compared closely with peers. The company’s latest quoted price now sits above its book value per share, and that is part of the valuation read behind the streak.
Univest data places the company in a small market capitalisation bracket at Rs 126.68 Cr, so HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak is easier to move in percentage terms than a much larger pharma name. The earnings per share of Rs 8.39 and book value of Rs 48.69 give the business context a per-share anchor. For this article type, that is the relevant company background: enough to interpret the streak, the valuation and the sector comparison without drifting into broader corporate profile language. HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak is therefore best seen as a price event inside a healthcare and pharmaceutical context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is HIMALAYA NUTRAVEDICS INDIA LIM Share Price rising today?
Ans. According to latest Univest data, the stock is trading higher in a second straight session. The pattern is confirmed, but no company-specific catalyst is established. The latest traded price stands at Rs 156.95.
What is HIMALAYA NUTRAVEDICS INDIA LIM Share Price today?
Ans. HIMALAYA NUTRAVEDICS INDIA LIM Share Price is Rs 156.95, up Rs 13.10, or 9.11%, from the previous close of Rs 143.85. The stock also touched the day’s high at the latest traded price.
What does the second straight session mean for HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak?
Ans. It means the stock has risen in two consecutive sessions, not just one. The cumulative move across the run is 30.85%, starting from Rs 119.95 on 2026-10-14, which makes the pattern more notable.
What is the market capitalisation of HIMALAYA NUTRAVEDICS INDIA LIM?
Ans. The market capitalisation is Rs 126.68 Cr. That places HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak in a much smaller company-size bracket than the listed healthcare peers used in the comparison section.
How is HIMALAYA NUTRAVEDICS INDIA LIM valued?
Ans. The stock has a P/E of 17.14 and a P/B of 2.95. EPS is Rs 8.39 and book value is Rs 48.69, while dividend yield is 0. The move has lifted the valuation multiples.
How does HIMALAYA NUTRAVEDICS INDIA LIM compare with sector benchmarks?
Ans. In same-industry context, the company’s P/E of 17.14 is below the benchmark median of 31.35 and the average of 46.92. Its P/B of 2.95 is slightly above the benchmark median of 2.84.
Which sector and industry does HIMALAYA NUTRAVEDICS INDIA LIM belong to?
Ans. The company belongs to Healthcare and the Pharmaceuticals & Drugs industry. That sector frame matters because the stock is being read against a large same-industry benchmark of 199 companies in the latest Univest comparison.
What is HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak telling investors now?
Ans. It shows a confirmed two-session upward pattern with a 30.85% cumulative move. The price action has outpaced the unchanged earnings and book-value base, so the valuation shift comes from price rather than a fresh fundamental figure.
Track HIMALAYA NUTRAVEDICS INDIA LIM Share Price on Univest
Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
HIMALAYA NUTRAVEDICS INDIA LIM Share Price Rise Streak can be followed on Univest for live share price updates, valuation ratios, 52-week levels and market insights. That makes it easier to compare today’s price action with the same earnings, book value and peer benchmarks used in this note. Univest keeps the stock context in one place for readers tracking the next move.
Recent Articles

Rotographics (India) Ltd. Hits Lower Circuit for the 2nd Straight Session on BSE, 15 October 2026
15 October 2026

Surani Steel Tubes Ltd. Hits Lower Circuit for the 2nd Straight Session on NSE, 15 October 2026
15 October 2026

Bansal Roofing Products Ltd. Hits Lower Circuit on BSE, 15 October 2026
15 October 2026

Asston Pharmaceuticals Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 15 October 2026
15 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Rotographics (India) Ltd. Hits Lower Circuit for the 2nd Straight Session on BSE, 15 October 2026
Surani Steel Tubes Ltd. Hits Lower Circuit for the 2nd Straight Session on NSE, 15 October 2026
Bansal Roofing Products Ltd. Hits Lower Circuit on BSE, 15 October 2026
Asston Pharmaceuticals Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 15 October 2026
Career Point Ltd. Hits Lower Circuit on BSE, 15 October 2026
Popular this week
Hoac Foods India Ltd. Hits Lower Circuit on NSE, 15 October 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





